Market Value Fluctuation Risk of Marketable Securities
First written in FY2018. 15 of 27 entries say "Mitigated", first in FY2020-Q3. Latest entry: 2026-08-07.
The whole theme swung hardest in 2019: 55 of 136 companies on the "Worse" side.
31 other companies' latest entry also says "Mitigated".
- 2026-08-07MitigatedEarnings
「その他有価証券評価差額金が1,196百万円増加した」
その他有価証券評価差額金が3,181百万円から4,377百万円へ増加し、市場性有価証券の評価差額が改善している。 - FY2026MitigatedAnnual report
「The valuation difference on other securities increased from ¥1,750 million at the end of the previous fiscal year to ¥3,181 million.」
The valuation difference on other securities increased from ¥1,750 million to ¥3,181 million, and the valuation difference on marketable securities improved. - 2026-05-08MitigatedEarnings
「その他有価証券評価差額金1,431百万円の増加」
その他有価証券評価差額金の増加により、市場性有価証券の評価差額はさらに改善した。 - FY2026-H1MitigatedAnnual report
「Valuation difference on other securities 1,750 2,218」
The valuation difference on other securities increased from ¥1,750 million at the end of the previous consolidated fiscal year to ¥2,218 million, continuing the improvement from the deficit in the valuation difference. - FY2025MitigatedAnnual report
「Valuation difference on other securities 799 1,750」
The valuation difference on other securities increased from ¥799 million at the end of the previous fiscal year to ¥1,750 million, improving from the negative impact of changes in the valuation of marketable securities. - FY2025-H1WorsenedAnnual report
「Valuation difference on other securities 799 663」
The valuation difference on other securities declined from ¥799 million at the end of the previous consolidated fiscal year to ¥663 million, reflecting the impact of changes in the valuation of marketable securities. - FY2024-Q2MitigatedAnnual report
「Valuation difference on other securities -433 267」
The valuation difference on other securities shifted from a deficit of ¥433 million at the end of the previous consolidated fiscal year to a surplus of ¥267 million, and the impact of changes in the valuation of marketable securities improved. - FY2024-Q1MitigatedAnnual report
「Valuation difference on other securities -433 -86」
The deficit in the valuation difference on other securities narrowed from -¥433 million at the end of the previous consolidated fiscal year to -¥86 million, and the impact of changes in the valuation of marketable securities improved. - FY2023MitigatedAnnual report
「Valuation difference on other securities -433」
The deficit in the valuation difference on other securities narrowed from -¥734 million at the end of the previous fiscal year to -¥433 million. - FY2023-Q3MitigatedAnnual report
「Valuation difference on other securities -734 -454」
The deficit in the valuation difference on other securities narrowed from -¥734 million at the end of the previous consolidated fiscal year to -¥454 million, and the impact of changes in the valuation of marketable securities improved. - FY2023-Q2WorsenedAnnual report
「Valuation difference on other securities -734 -751」
The deficit in the valuation difference on other securities widened from -¥734 million at the end of the previous consolidated fiscal year to -¥751 million, and the impact of changes in the valuation of marketable securities deteriorated. - FY2023-Q1WorsenedAnnual report
「Valuation difference on other securities -734 -759」
The deficit in the valuation difference on other securities widened from ¥734 million at the end of the previous consolidated fiscal year to ¥759 million. - FY2022WorsenedAnnual report
「Valuation difference on other securities -734」
The deficit in the valuation difference on other securities widened from -¥702 million at the end of the previous fiscal year to -¥734 million. - FY2022-Q3WorsenedAnnual report
「Valuation difference on other securities -702 -839」
The deficit in the valuation difference on other securities widened from -¥702 million at the end of the previous consolidated fiscal year to -¥839 million. - FY2022-Q2MitigatedAnnual report
「Valuation difference on other securities -702 -699」
The deficit in the valuation difference on other securities narrowed from -¥702 million at the end of the previous consolidated fiscal year to -¥699 million. - FY2022-Q1WorsenedAnnual report
「Valuation difference on other securities -702 -713」
The deficit in the valuation difference on other securities widened from ¥702 million at the end of the previous consolidated fiscal year to ¥713 million. - FY2021MitigatedAnnual report
「Valuation difference on other securities -702」
The deficit in the valuation difference on other securities narrowed from -¥1,061 million at the end of the previous fiscal year to -¥702 million. - FY2021-Q3MitigatedAnnual report
「Valuation difference on other securities -1,061 -990」
The deficit in the valuation difference on other securities narrowed from -¥1,061 million at the end of the previous consolidated fiscal year to -¥990 million, and the impact of changes in the valuation of marketable securities improved. - FY2021-Q2MitigatedAnnual report
「Valuation difference on other securities -1,061 -989」
The deficit in the valuation difference on other securities narrowed from -¥1,061 million at the end of the previous consolidated fiscal year to -¥989 million, and the impact of changes in the valuation of marketable securities improved. - FY2021-Q1MitigatedAnnual report
「Valuation difference on other securities -1,061 -986」
The deficit in the valuation difference on other securities narrowed from -¥1,061 million at the end of the previous consolidated fiscal year to -¥986 million, and the impact of changes in the valuation of marketable securities improved. - FY2020WorsenedAnnual report
「Valuation difference on other securities -574 -1,061」
The deficit in the valuation difference on other securities widened from -¥574 million at the end of the previous fiscal year to -¥1,061 million, and the impact of changes in the valuation of marketable securities deteriorated. - FY2020-Q3MitigatedAnnual report
「Valuation difference on other securities -574 -592」
The deficit in the valuation difference on other securities narrowed from -¥633 million in the previous quarter to -¥592 million, and the impact of changes in the valuation of marketable securities improved from the immediately preceding quarter. - FY2020-Q2WorsenedAnnual report
「Valuation difference on available-for-sale securities △ ¥574 million △ ¥633 million」
The negative valuation difference on available-for-sale securities widened from ¥574 million at the end of the previous consolidated fiscal year to ¥633 million, indicating a deterioration in the impact of valuation fluctuations in marketable securities. - FY2020-Q1WorsenedAnnual report
「Valuation difference on available-for-sale securities △ ¥574 million △ ¥721 million」
The negative valuation difference on available-for-sale securities widened from ¥574 million at the end of the previous consolidated fiscal year to ¥721 million, indicating a deterioration in the impact of valuation fluctuations in marketable securities. - FY2019RestatedAnnual report
「Valuation difference on available-for-sale securities △ ¥574 million」
The negative valuation difference on available-for-sale securities continued, and the impact of fair-value fluctuations in marketable securities was also reflected in full-year results. - FY2019-Q3MaterialisedAnnual report
「Valuation difference on available-for-sale securities △ ¥361 million △ ¥588 million Total accumulated other comprehensive income △ ¥350 million △ ¥572 million」
The valuation difference on available-for-sale securities declined from △¥361 million at the end of the previous consolidated fiscal year to △¥588 million, demonstrating the impact of valuation fluctuations in marketable securities. - FY2018First statedAnnual report
「Depending on fluctuations in stock markets, interest rates and other factors, the fair value of securities may be affected, which may in turn affect the Group’s operating results and financial position.」
Fair-value fluctuations in the securities held due to changes in stock markets and interest rates are identified as a risk.